The Aedes mosquito is spreading a deadly virus around the world for which the CDC has issued a “Level 2” advisory warning for U.S. travelers
09/05/2025 // S.D. Wells // 1.5K Views
Tags: badhealth, bill gates mosquito, bill gates vaccine, brazil mosquito, CDC, chikungunya, dangeorus, health warning, mosquito pandemic, new pandemic, new plandemic, new scamdemic, outbreak, Plague, Public Health
Health officials are warning U.S. travelers about the rapid global spread of chikungunya, a mosquito-borne virus that can cause sudden, debilitating joint pain lasting for months. Since the beginning of 2025, over 240,000 cases and at least 90 deaths have been reported in 16 countries spanning the Americas, Africa, Asia, and Europe. The U.S. Centers for Disease Control and Prevention (CDC) has expanded its Level 2 travel advisory — urging “enhanced precautions” — to include Kenya, Madagascar, Somalia, and Sri Lanka, in addition to previously affected regions such as China’s Guangdong Province, where an outbreak of more than 10,000 cases triggered local COVID-like containment measures.
- The CDC has expanded its Level 2 travel advisory for the chikungunya virus as outbreaks spread globally, now including countries such as Kenya, Madagascar, Somalia, and Sri Lanka, alongside hotspots in China, Brazil, and Bolivia.
- Chikungunya, spread by Aedes mosquitoes, causes high fever and severe joint pain that can leave people unable to move normally for months; severe complications affecting the heart and brain are rare but possible.
- S. health officials warn that increased international travel could lead to local mosquito transmission in America, as infected travelers returning from outbreak regions could be bitten and spark domestic spread.
- There is no specific treatment for chikungunya, though two vaccines are available for travelers; prevention relies on avoiding mosquito bites through repellents, protective clothing, and staying away from outbreak areas.
A travel advisory issued over the deadly GM-mosquito-spread chikungunya virus has been expanded as it continues to spread around the world
The virus, spread by (Bill Gates’) GMO Aedes mosquitoes (which also transmit dengue, yellow fever, and Zika), is not contagious between people, but it poses a growing risk of local transmission in the U.S. via infected travelers. The U.S. has not experienced sustained local spread since 2019, but with 4.7 million international passengers flying daily, experts warn that an infected traveler bitten by a local mosquito could reignite domestic outbreaks. Currently, 55 cases have been reported in the U.S. in 2025 — all linked to travel.
Brazil and Bolivia are current hotspots in the Americas, with Brazil alone reporting more than 210,000 cases. In Asia, China remains a focal point, battling its largest-ever outbreak. Authorities there have deployed drones, insecticide, “cannibal” mosquitoes, and even electricity cuts in uncooperative neighborhoods to contain spread. In Foshan, patients have been quarantined and disinfectant sprayed across public areas — echoing pandemic-era restrictions.
Travel and cruise operators have joined the call for vigilance. Norwegian Cruise Line has advised passengers to Italy to wear insect-repellent-treated clothing after both dengue and chikungunya were locally detected there for the first time. In the U.S., some localities have taken precautionary action: one Massachusetts town last September closed parks nightly after a resident contracted eastern equine encephalitis, another mosquito-borne illness.
Chikungunya typically incubates for three to seven days. Symptoms include sudden high fever (over 102°F), rash, headache, nausea, muscle aches, conjunctival redness, and severe joint pain, particularly in the hands and feet. Though mortality is generally low (less than 1 in 1,000 cases), severe complications can affect the heart, brain, or organs, occasionally resulting in organ failure or irregular heart rhythms. Pregnant women infected near delivery may pass the virus to newborns, sometimes causing serious illness.
There is no specific treatment. Care focuses on symptom management with pain and fever reducers, though two vaccines are available for travelers heading to outbreak areas. The CDC classifies chikungunya as a “nationally notifiable” condition, allowing health agencies to track and monitor imported cases.
Chikungunya’s trajectory underscores how interconnected travel, climate, and vector biology are reshaping infectious disease risk. The current wave recalls the 2014 spike — when U.S. territories saw over 2,700 cases — but now with broader geographic reach and intensified global travel, officials stress that prevention (avoiding mosquito bites and heeding travel advisories) remains the most effective defense.
Bookmark plague.info to your favorite independent websites for updates on TWO HUNDRED new gain-of-function viruses NIH, CDC and WHO plan to release into the “wild” while blaming infected bat soup eaters at the Wuhan wet market.
Sources for this article include:
Comments